Search over 3,000 reports

    Opana ER- Drug Insights, 2017

    Opana ER- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0367
    DelveInsight's pharmaceuticals report, " Opana ER Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Opana ER covering the historical global sales and also provides the Opana ER sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Opana ER and emerging therapies in this space.

    Scope

    A review of the Opana ER, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Opana ER- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Pharmacology
    Pharmacodynamics
    Pharmacokinetics
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Opana ER Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1: Opana ER, Description
    Table 2: Opana ER, Product Details
    Table 3: Opana ER, Historical Sales (in million USD)
    Table 4: Opana ER, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Opana ER, Patent Details
    Table 6: Company, Overview
    Table 7: Opana ER Major Competitors Opana ER
    Table 8: Emerging Therapies
    Figure 1: Opana ER, Historical Sales (in million USD)
    Figure 2: Opana ER, Forecasted Sales from 2017-2019 (in million USD)
    Opana ER
    Endo Pharmaceuticals
    Pain reliever
    Opana ER Marketed Drugs Overview
    Opana ER Market Assessment
    Opana ER API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Opana ER US DMF
    Opana ER US Drug Master Files
    Opana ER Active Substance Master File/ EUDMF
    Opana ER Generic players
    Opana ER Patent Expiration
    Opana ER Patent Exclusivity
    Opana ER API Manufacturers
    Opana ER Global Forecasted Sales Figure
    Opana ER API Route of Synthesis
    Opana ER Market sales
    Opana ER SWOT Analysis
    Opana ER Pipeline
    • Single User License
      (20% Off)
      $1,000.00
      $800
    • Site License
      (30% Off)
      $2,000.00
      $1400
    • Global License
      (40% Off)
      $3,000.00
      $1800

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap